Department of Endocrinology and Diabetes, Diabetes Treatment Center, Prince Sultan Military Medical City, Riyadh, Saudi Arabia
Review Article
COVID-19 in Saudi Arabians with diabetic mellitus
Author(s): Abdulghani Al Saeed*
The purpose of this review is to discuss the status of COVID-19 among
people with diabetes, those who have just been diagnosed with diabetes,
diabetic ketoacidosis, and programmatic efforts like vaccinations at the
present time. Diabetes has been identified as one of the most common
comorbidities among COVID-19 patients in the majority of studies
conducted in Saudi Arabia. There are currently only a few studies from
Saudi Arabia on COVID-19-related newly diagnosed diabetes and diabetic
ketoacidosis. Comprehensive guidelines and vaccinations in order of
priority have been implemented by the Saudi ministry to reduce the impact
of COVID-19 on diabetics. The utilization of tele health services significantly
increased in Saudi Arabia's diabetes clinics during the COVID-19 pandemic.
To manage the effects of COVID-19 on diabetics, targeted, evidence-based
.. View More»
DOI:
10.35248/2155-6156.1000973
